Saturday, September 26, 2026
MiningNewsTerminal
Saturday, September 26, 2026 Admin

TES.V ·

A finder’s fees may be payable in cash of up to 6% of the proceeds of the Private Placement in accordance with TSXV policies.

Financings

TESORO MINERALS CORP.

Suite 108, 744 West Hastings Street

Vancouver, British Columbia

Canada V6C 1A5

TESORO MINERALS ANNOUNCES $250,000 PRIVATE PLACEMENT

(Not for distribution to United States newswire services or for dissemination in

the United States of America)

April 5, 2023 (TSX Venture: TES) – Tesoro Minerals Corp., (“Tesoro” or the “Company”) is pleased

to announce a non-brokered private placement offering (the “Offering”) of up to 7,142,857 common

shares at a price of $0.035 for aggregate gross proceeds of C$250,000.00.

The closing of the Offering is anticipated to occur on or before April 30, 2023 (the “Closing Date”)

and is subject to certain conditions including, but not limited to, the receipt of all necessary

regulatory approvals, including the acceptance of the TSX Venture Exchange. The securities

issued under the Offering will be subject to a statutory hold period in Canada expiring four months

and one day from the Closing Date.

A finder’s fees may be payable in cash of up to 6% of the proceeds of the Private Placement in

accordance with TSXV policies.

The net proceeds of the offering are expected to be used by Tesoro for general working capital

and operating expenses to support business efforts.

About Tesoro

The Company has assembled a team of experienced geoscientists with extensive exploration

experience in the Americas with the aim of acquiring further assets. For further information on the

Company please contact Scott McLean, Interim President & CEO at [email protected] or

(604) 210-2305.

On Behalf of the Board of Directors

“Scott McLean”

Scott McLean

Interim President & CEO

Neither the TSX Venture Exchange no r the Investment Industry Regulato ry Organization of Canada accepts

responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United

States of America. The securi ties have not been and will not be registered under the United States Securities Act of

1933 (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or

to U.S. Persons (as defined in the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable

state securities laws, or an exemption from such registration is available.

Cautionary Statements regarding Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information. These statements relate to

future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected",

"estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify

forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing

of such future events. Actual future results may differ materially.

All statements including, without limita tion, statements relating to the ability to complete the offering on the proposed

terms or at all, anticipated use of proceeds from the offering and receip t of regulatory approvals with respect to the

offering as well as any other future plans, objectives or expectations of the Company ar e forward-looking statements

that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate

and actual results and future events could differ materially from those anticipated in such statements. Important factors

that could cause actual results to differ materially from the Company's plans or expectations include risks relating to the

availability of capital and financing, general economic, mark et or business conditions, regulatory changes, the COVID-

19 pandemic or other similar health crisis, timeliness of government or regulatory approvals and other risks detailed

herein and from time to time in the filings made by the Company with securities regulators. The Company expressly

disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new

information, future events or otherwise except as otherwise required by applicable securities legislation.